Advagene Biopharma Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced operating loss was TWD 35.774 million compared to TWD 64.207 million a year ago. Net loss was TWD 34.602 million compared to TWD 63.905 million a year ago. Basic loss per share was TWD 0.78 compared to TWD 1.98 a year ago.